Robuta

Sponsor of the Day: Jerkmate
https://turkjgastroenterol.org/index.php/tjg/article/view/4428 De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing,... de novoliver transplantationcohort studymalignanciesmulticenter https://www.mskcc.org/research-areas/topics/hematologic-malignancies Hematologic Malignancies | Memorial Sloan Kettering Cancer Center Learn about the work Memorial Sloan Kettering scientists are doing in the area of hematologic malignancies. memorial sloan ketteringhematologic malignanciescancer center https://diagnostics.roche.com/global/en/products/product-category/health-topic/oncology/blood-cancer.html Blood cancers (hematologic malignancies) Roche’s comprehensive portfolio of hematopathology solutions helps drive diagnostic certainty for blood cancers and hematologic malignancies including lymphoma. blood cancershematologic malignancies https://www.sfb1709.de/ New Therapies for Myeloid Malignancies - SFB 1709 Apr 17, 2026 - Discover groundbreaking insights on Cellular Plasticity in Myeloid Malignancies and new therapies aimed at overcoming cancer resistance. new therapiesmyeloid malignanciessfb1709 https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancerhematologic-malignancies-approval-notifications Oncology (Cancer)/Hematologic Malignancies Approval Notifications | FDA FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology. Please refer to Drugs@FDA for the... oncology cancerhematologic malignanciesapprovalnotificationsfda https://www.dana-farber.org:443/for-physicians/clinical-resources/hematologic-malignancies Hematologic Malignancies Resources and Support | Dana-Farber Cancer Institute Find out how we partner with referring providers to provide more patients access to the most advanced care and treatment available for hematologic... support dana farberhematologic malignanciescancer instituteresources https://www.frontiersin.org/journals/oncology/sections/hematologic-malignancies Frontiers in Oncology | Hematologic Malignancies Explore global open-access research on hematologic malignancies, advancing understanding and treatment of blood cancers through clinical and molecular studies. hematologic malignanciesfrontiersoncology https://www.centerwatch.com/clinical-trials/listings/condition/1098/b-cell-malignancies B Cell Malignancies Clinical Research Trials | CenterWatch B-cell malignancies refer to a group of cancers that affect the B-cells of the immune system, which produce antibodies to fight infections. These cancers can... clinical research trialsb cellmalignanciescenterwatch https://www.ncbi.nlm.nih.gov/books/NBK568319/ RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies - GeneReviews® - NCBI... RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an... myeloid malignanciesfamilialplateletdisorderassociated https://medicine.yale.edu/cancer/research/clinical/teams/leukdart/ Leukemia and Myeloid Malignancies | Yale Cancer Center yale cancer centermyeloid malignanciesleukemia https://www.dana-farber.org/for-physicians/clinical-resources/hematologic-malignancies/advances-newsletter/2025-issue-21 Advances in Hematologic Malignancies Issue 21, Fall 2025 | Dana-Farber Cancer Institute Stay up to date on the latest research and clinical advances in hematologic malignancies with Dana-Farber's Fall 2025 newsletter. dana farber cancerhematologic malignanciesissue 21fall 2025advances